Results 181 to 190 of about 11,084,548 (300)
ISOLDE Experiments Committee: Minutes for the twenty-sixth meeting on Monday 8 February 1999 [PDF]
CERN. Geneva. ISOLDE Experiments Committee
core
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola +12 more
wiley +1 more source
Mass measurement of very short half-lived nuclei [PDF]
CERN. Geneva. ISOLDE Experiments Committee
core
ATF4‐mediated stress response as a therapeutic vulnerability in chordoma
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone +11 more
wiley +1 more source
The ATG8 E3-like ligases sense lysosomal damage and initiate ESCRT-mediated membrane repair. [PDF]
Corkery DP +5 more
europepmc +1 more source
Minutes of the 52nd meeting, 7 September 1999 [PDF]
CERN. Geneva. LEP Experiments Committee
core
Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken +7 more
wiley +1 more source
In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation. [PDF]
Calderón L +9 more
europepmc +1 more source
LEP Experiments Committee: Minutes of the 45th meeting, 29 May 1997 [PDF]
CERN. Geneva. LEP Experiments Committee
core
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source

